Immediate Impact
1 by Nobel laureates 5 from Science/Nature 63 standout
Citing Papers
Radiotherapy toxicities: mechanisms, management, and future directions
2025 Standout
Analysis of Breast Cancer Mortality in the US—1975 to 2019
2024 Standout
Works of A. D. Colevas being referenced
A phase I pharmacokinetic and target validation study of the novel anti-tubulin agent E7389: A California Cancer Consortium trial
2005
The NCI Common Terminology Criteria for Adverse Events (CTCAE) v 3.0 is the new standard for oncology clinical trials
2004
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| A. D. Colevas | 386 | 111 | 55 | 349 | 24 | 639 | |
| Lisa Ley | 323 | 87 | 108 | 272 | 30 | 647 | |
| Véronique Haddad | 318 | 101 | 87 | 272 | 23 | 530 | |
| Yi‐Hung Carol Tan | 248 | 195 | 90 | 338 | 32 | 686 | |
| Hima Patel | 267 | 122 | 70 | 367 | 19 | 652 | |
| Jian Ma | 262 | 163 | 115 | 399 | 21 | 609 | |
| Maureen E. Lane | 302 | 165 | 90 | 230 | 25 | 692 | |
| Claire E. Repellin | 309 | 250 | 99 | 469 | 20 | 715 | |
| Jolien Van den Bossche | 301 | 101 | 105 | 241 | 22 | 525 | |
| John D. Miedler | 256 | 89 | 124 | 331 | 18 | 612 | |
| Qiang He | 183 | 71 | 98 | 279 | 27 | 552 |
All Works
Loading papers...